Blog
LimmaTech Biologics Secures Exclusive Rights for Breakthrough Vaccine
🔬 LimmaTech Biologics secures license for AbVacc's LBT-SA7 vaccine! Exciting news in the fight against hospital-acquired infections. 💉✨🌍 biotech vaccine
Gavi Boosts Vaccine Manufacturing in Africa: A Game-Changer for Health and Economy!
🌍 Gavi, the Vaccine Alliance, is working to improve vaccine manufacturing capabilities in Africa. The initiative aims to establish vaccine manufacturing hubs on the continent to increase its self-sufficiency.💉
Revolutionizing Cell & Gene Therapy: Cutting-edge Standards
📢 Polyplus & MarkHerz partner to develop cell & gene therapy standards. Decrease costs, increase quality & exchange knowledge. 💼💡💪
Novartis Sells French Biomanufacturing Facility to Seqens Transforming It into a Leading CDMO
💼 Novartis sells its biomanufacturing facility in France to Seqens, who plans to expand it into a CDMO. 💪🔬
Upstream vs Downstream Productivity: Who Will Win?
📢 Will downstream productivity catch up with the upstream in 2024? Discover how the bioprocessing industry tackles challenges and embraces opportunities. ⏭️👥🌍
Protein Problems Unlocked: Overcoming Manufacturing Challenges
Unlocking Protein Problems 📅 November 28, 2023 ⚠️ Even promising protein projects can fail due to technical difficulties in manufacturing at a large scale. 👨🔬 Manufacturing expertise is often overlooked but is crucial in avoiding challenges in protein manufacture. 🚀 Conventional solutions like contract manufacturing organizations may fall short in addressing complex protein problems. 🧬 QTL technology enables the resolution of technical challenges in protein projects by optimizing manufacturing strains. 💪 QTL technology has shown its ability to remove roadblocks and make projects viable again.
Affordable Breakthrough: Revolutionizing Monoclonal Antibodies
🔬 Recent innovations in cell culture media make monoclonal antibody development more affordable, revolutionizing biological therapeutics. 💉👩🔬
The Game-Changing Future of Cell and Gene Therapy Relies on Recombinant Albumin
🔬 Stay updated on the future of cell and gene therapy with reliable and affordable recombinant albumin. 🚀 CellTherapy GeneTherapy
Revolutionary Partnership Automates Cell Therapy Manufacturing
🚀 908 Devices and Terumo BCT collaborate to automate cell therapy using MAVEN and Quantum Cell Expansion System. 🧪📈🔄
ReciBioPharm Boosts mRNA Therapy Manufacturing with Acuitas Partnership
📣 ReciBioPharm and Acuitas Therapeutics expand partnership to provide tech transfer and manufacturing services for mRNA-based therapeutics and vaccines. 🏭🔬
